Advertisement

Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator

  • Jost HillenkampEmail author
  • Vladimir Surguch
  • Carsten Framme
  • Veit-Peter Gabel
  • Helmut G. Sachs
Retinal Disorders

Abstract

Aim

To compare the efficacy of pars plana vitrectomy (ppV) with intravitreal injection of recombinant tissue plasminogen activator (rtPA) and gas versus ppV with subretinal injection of rtPA and intravitreal injection of gas.

Methods

Nonrandomized, retrospective, interventional, comparative consecutive series including 47 patients with submacular hemorrhage. Eighteen patients were treated with ppV, intravitreal injection of rtPA and 20% SF6 gas [group A: mean age 78 years, mean duration of symptoms 6.6 days, 15 age-related macular degeneration (AMD), three retinal arterial macroaneurysm (RAMA)]. Twenty-nine patients were treated with ppV, subretinal injection of rtPA and intravitreal injection of SF6 gas (group B: mean age 75 years, mean duration of symptoms 5.9 days, 26 AMD, two RAMA, one blunt ocular trauma). The main outcome measure was complete displacement of submacular hemorrhage from the fovea.

Results

Complete displacement of submacular hemorrhage was achieved in less patients in group A (22%) than in group B (55%) (p = 0.025). In group A, mean best-corrected visual acuity (BCVA) change was logMAR -0.14, standard deviation (SD) = 0.64, and in group B logMAR -0.32, SD = 0.68 without statistically significant difference between the two groups (p = 0.2, Mann–Whitney test). Complications (retinal detachment, vitreous hemorrhage, and recurrence of submacular hemorrhage) were more frequent in group B than in group A.

Conclusion

ppV with subretinal injection of rtPA and intravitreal injection of gas was more effective than ppV with intravitreal injection of rtPA and gas in terms of complete displacement of submacular hemorrhage; however, it may be associated with a higher rate of postoperative complications. Functional improvement in the majority of patients suggests the absence of direct retinal toxicity of subretinally applied rtPA.

Keywords

Age-related macular degeneration Retinal arterial macroaneurysma Recombinant tissue plasminogen activator Submacular hemorrhage 

Notes

Acknowledgments

We thank Dipl.-Math. Elfriede Fritzer, Institute for Medical Statistics and Informatics, University of Kiel for expert statistical advice.

References

  1. 1.
    Avery RL, Fekrat S, Hawkins BS et al (1996) Natural history of subfoveal hemorrhage in age-related macular degeneration. Retina 16:183–189CrossRefPubMedGoogle Scholar
  2. 2.
    Scupola A, Coscas G, Soubrane G et al (1999) Natural history of macular subretinal hemorrahge in age-related macular degeneration. Ophthalmologica 213:97–102CrossRefPubMedGoogle Scholar
  3. 3.
    Glatt H, Machemer R (1982) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94:762–773CrossRefPubMedGoogle Scholar
  4. 4.
    Toth CA, Mourse LS, Hjemeland LM, Landers MB III (1991) Fibrin early retinal damage after experimental subretinal hemorrahge. Arch Ophthalmol 109:723–729PubMedGoogle Scholar
  5. 5.
    Gillies A, Lahav M (1983) Absorption of retinal and subretinal hemorrhages. Ann Ophthalmol 15:1068–1074PubMedGoogle Scholar
  6. 6.
    Bhisitkul RB, Winn BJ, Lee OT et al (2008) Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage. Invest Ophthalmol Vis Sci 49:4071–4077CrossRefPubMedGoogle Scholar
  7. 7.
    El Baba F, Jarrett WH (1986) Massive hemorrhage complicating age-related macular degeneration: Clinicopathologic correlation and role of anticoaggulants. Ophthalmology 93:1581–1592PubMedGoogle Scholar
  8. 8.
    Gabel VP (1991) Subretinal lavage in fresh hemorrhage in macular degeneration. Fortschr Ophthalmol 88:135–137 [German]PubMedGoogle Scholar
  9. 9.
    Vander JF, Federman JL, Greven C, Slusher MM, Gabel VP (1991) Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 98:23–27PubMedGoogle Scholar
  10. 10.
    De Juan E Jr, Machemer R (1988) Vitreous surgery for hemorrhagic and fibrous complication of age-related macular degeneration. Am J Ophthalmol 105:25–29PubMedGoogle Scholar
  11. 11.
    Lewis H (1994) Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118:559–568PubMedGoogle Scholar
  12. 12.
    Peyman GA, Nelson NC Jr, Alturki W et al (1991) Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 22:575–582PubMedGoogle Scholar
  13. 13.
    Bressler NM, Bressler SB, Childs AL, Submacular Surgery Trials (SST) Research Group et al (2004) Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report No. 13. Ophthalmology 111:1993–2006CrossRefPubMedGoogle Scholar
  14. 14.
    Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ (2007) Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 27:321–328CrossRefPubMedGoogle Scholar
  15. 15.
    Hesse L, Schmidt J, Kroll P (1999) Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 237:273–277CrossRefPubMedGoogle Scholar
  16. 16.
    Hassan AS, Johnson MW, Schneiderman TE et al (1999) Management of submacular hemorrhage with intravitreous tPA injection and pneumatic displacement. Ophthalmology 106:1900–1907CrossRefPubMedGoogle Scholar
  17. 17.
    Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS (2001) Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement Arch Ophthalmol 119:28–32Google Scholar
  18. 18.
    Meyer CH, Scholl HP, Eter N et al (2008) Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol 86:490–494CrossRefPubMedGoogle Scholar
  19. 19.
    Kamei M, Misono K, Lewis H (1999) A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 128:739–746CrossRefPubMedGoogle Scholar
  20. 20.
    Takeuchi A, Kricorian G, Yao XY et al (1994) The rate and source of albumin entry into saline-filled experimental retinal detachments. Invest Ophthalmol Vis Sci 35:3792–3598PubMedGoogle Scholar
  21. 21.
    Jackson TL, Antcliff RJ, Hillenkamp J, Marshall J (2003) Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci 44:2141–2146CrossRefPubMedGoogle Scholar
  22. 22.
    Heiduschka P, Fietz H, Hofmeister S et al (2007) Penetration of Bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48:2814–2823CrossRefPubMedGoogle Scholar
  23. 23.
    Haupert CL, McCuen BW 2nd, Jaffe GJ (2001) Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 131:208–215CrossRefPubMedGoogle Scholar
  24. 24.
    Olivier S, Chow DR, Packo KH (2004) Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 111:1201–1208CrossRefPubMedGoogle Scholar
  25. 25.
    Hattenbach LO, Klais C, Koch FHJ, Gümbel HOC (2001) Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 108:1485–1492CrossRefPubMedGoogle Scholar
  26. 26.
    Schulze SD, Hesse L (2002) Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol 240:717–720CrossRefPubMedGoogle Scholar
  27. 27.
    Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y (1998) Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 116:1326–1332PubMedGoogle Scholar
  28. 28.
    Lincoff H, Kreissig I, Stopa M et al (2008) A 40 degrees gaze down position for pneumatic displacement of submacular hemorrhage: clinical application and results. Retina 28:56–59CrossRefPubMedGoogle Scholar
  29. 29.
    Johnson MW, Olsen KR, Hernandez E (1991) Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina 11:250–258CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Jost Hillenkamp
    • 1
    Email author
  • Vladimir Surguch
    • 2
  • Carsten Framme
    • 2
  • Veit-Peter Gabel
    • 2
  • Helmut G. Sachs
    • 2
  1. 1.Department of OphthalmologyUniversity Medical Center Schleswig-HolsteinKielGermany
  2. 2.University of RegensburgRegensburgGermany

Personalised recommendations